questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Phénols
Catéchols
Catécholamines
Catécholamines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Catécholamines
Diagnostic médical
Tests de laboratoire
Catécholamines
Imagerie médicale
Tumeurs surrénaliennes
Tests génétiques
Syndromes héréditaires
Symptômes
5
Palpitations
Fréquence cardiaque
Maux de tête
Hypertension
Troubles de l'humeur
Anxiété
Nausées
Troubles gastro-intestinaux
Prévention
5
Prévention
Gestion du stress
Mode de vie sain
Alimentation équilibrée
Stress
Techniques de relaxation
Examens médicaux
Détection précoce
Éducation à la santé
Symptômes
Traitements
5
Traitement médical
Chirurgie
Bêta-bloquants
Inhibiteurs de la monoamine oxydase
Chirurgie
Phéochromocytome
Médecine alternative
Gestion du stress
Suivi médical
Pression artérielle
Complications
5
Complications
Hypertension
Diabète
Régulation de la glycémie
Troubles psychologiques
Anxiété
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Tabagisme
Système cardiovasculaire
Stress émotionnel
Production de catécholamines
Maladies endocriniennes
Production de catécholamines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Catécholamines : Questions médicales les plus fréquentes",
"headline": "Catécholamines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Catécholamines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Catécholamines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Catéchols",
"url": "https://questionsmedicales.fr/mesh/D002396",
"about": {
"@type": "MedicalCondition",
"name": "Catéchols",
"code": {
"@type": "MedicalCode",
"code": "D002396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Carbidopa",
"alternateName": "Carbidopa",
"url": "https://questionsmedicales.fr/mesh/D002230",
"about": {
"@type": "MedicalCondition",
"name": "Carbidopa",
"code": {
"@type": "MedicalCode",
"code": "D002230",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.200.538.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dobutamine",
"alternateName": "Dobutamine",
"url": "https://questionsmedicales.fr/mesh/D004280",
"about": {
"@type": "MedicalCondition",
"name": "Dobutamine",
"code": {
"@type": "MedicalCode",
"code": "D004280",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.220"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dopamine",
"alternateName": "Dopamine",
"url": "https://questionsmedicales.fr/mesh/D004298",
"about": {
"@type": "MedicalCondition",
"name": "Dopamine",
"code": {
"@type": "MedicalCode",
"code": "D004298",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hydroxydopamines",
"alternateName": "Hydroxydopamines",
"url": "https://questionsmedicales.fr/mesh/D006892",
"about": {
"@type": "MedicalCondition",
"name": "Hydroxydopamines",
"code": {
"@type": "MedicalCode",
"code": "D006892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342.478"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Oxidopamine",
"alternateName": "Oxidopamine",
"url": "https://questionsmedicales.fr/mesh/D016627",
"about": {
"@type": "MedicalCondition",
"name": "Oxidopamine",
"code": {
"@type": "MedicalCode",
"code": "D016627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342.478.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Oxidopamine",
"alternateName": "Oxidopamine",
"url": "https://questionsmedicales.fr/mesh/D016627",
"about": {
"@type": "MedicalCondition",
"name": "Oxidopamine",
"code": {
"@type": "MedicalCode",
"code": "D016627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342.478.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Épinéphrine",
"alternateName": "Epinephrine",
"url": "https://questionsmedicales.fr/mesh/D004837",
"about": {
"@type": "MedicalCondition",
"name": "Épinéphrine",
"code": {
"@type": "MedicalCode",
"code": "D004837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désoxyadrénaline",
"alternateName": "Deoxyepinephrine",
"url": "https://questionsmedicales.fr/mesh/D003846",
"about": {
"@type": "MedicalCondition",
"name": "Désoxyadrénaline",
"code": {
"@type": "MedicalCode",
"code": "D003846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métanéphrine",
"alternateName": "Metanephrine",
"url": "https://questionsmedicales.fr/mesh/D008676",
"about": {
"@type": "MedicalCondition",
"name": "Métanéphrine",
"code": {
"@type": "MedicalCode",
"code": "D008676",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Racépinéfrine",
"alternateName": "Racepinephrine",
"url": "https://questionsmedicales.fr/mesh/D064705",
"about": {
"@type": "MedicalCondition",
"name": "Racépinéfrine",
"code": {
"@type": "MedicalCode",
"code": "D064705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.825"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Isoprénaline",
"alternateName": "Isoproterenol",
"url": "https://questionsmedicales.fr/mesh/D007545",
"about": {
"@type": "MedicalCondition",
"name": "Isoprénaline",
"code": {
"@type": "MedicalCode",
"code": "D007545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.649"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Orciprénaline",
"alternateName": "Metaproterenol",
"url": "https://questionsmedicales.fr/mesh/D009921",
"about": {
"@type": "MedicalCondition",
"name": "Orciprénaline",
"code": {
"@type": "MedicalCode",
"code": "D009921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.660"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fénotérol",
"alternateName": "Fenoterol",
"url": "https://questionsmedicales.fr/mesh/D005280",
"about": {
"@type": "MedicalCondition",
"name": "Fénotérol",
"code": {
"@type": "MedicalCode",
"code": "D005280",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.660.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Norépinéphrine",
"alternateName": "Norepinephrine",
"url": "https://questionsmedicales.fr/mesh/D009638",
"about": {
"@type": "MedicalCondition",
"name": "Norépinéphrine",
"code": {
"@type": "MedicalCode",
"code": "D009638",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.830"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "alpha-Méthyl-noradrénaline",
"alternateName": "Nordefrin",
"url": "https://questionsmedicales.fr/mesh/D008771",
"about": {
"@type": "MedicalCondition",
"name": "alpha-Méthyl-noradrénaline",
"code": {
"@type": "MedicalCode",
"code": "D008771",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.830.400"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Catécholamines",
"alternateName": "Catecholamines",
"code": {
"@type": "MedicalCode",
"code": "D002395",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Li Li",
"url": "https://questionsmedicales.fr/author/Li%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Seattle Children's Research Institute, Seattle, WA 98101, USA. Electronic address: lili1@uw.edu."
}
},
{
"@type": "Person",
"name": "Esther M Li",
"url": "https://questionsmedicales.fr/author/Esther%20M%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Psychology, University of Washington, Seattle, WA 98105, USA."
}
},
{
"@type": "Person",
"name": "Jiesi Feng",
"url": "https://questionsmedicales.fr/author/Jiesi%20Feng",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China."
}
},
{
"@type": "Person",
"name": "Yulong Li",
"url": "https://questionsmedicales.fr/author/Yulong%20Li",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China; PKU-IDG/McGovern Institute for Brain Research, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, New Cornerstone Science Laboratory, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China."
}
},
{
"@type": "Person",
"name": "Michael R Bruchas",
"url": "https://questionsmedicales.fr/author/Michael%20R%20Bruchas",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA; Department of Pharmacology, University of Washington, Seattle, WA 98195, USA. Electronic address: mbruchas@uw.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Levodopa versus levodopa sparing in early parkinson's disease: can we meet halfway?",
"datePublished": "2024-07-17",
"url": "https://questionsmedicales.fr/article/39028854",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.24875/RIC.24000076"
}
},
{
"@type": "ScholarlyArticle",
"name": "The combination of levodopa with levodopa-metabolizing enzyme inhibitors prevents severe fever with thrombocytopenia syndrome virus infection in vitro more effectively than single levodopa.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36871824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jiac.2023.02.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Associations between variants in levodopa metabolic pathway genes and levodopa-induced dyskinesia in Parkinson's disease.",
"datePublished": "2023-02-21",
"url": "https://questionsmedicales.fr/article/36813078",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neulet.2023.137140"
}
},
{
"@type": "ScholarlyArticle",
"name": "Levodopa, homocysteine and Parkinson's disease: What's the problem?",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36922273",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2023.105357"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel treatment option for intrajejunal levodopa administration.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36723452",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14737175.2023.2176222"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phénols",
"item": "https://questionsmedicales.fr/mesh/D010636"
},
{
"@type": "ListItem",
"position": 8,
"name": "Catéchols",
"item": "https://questionsmedicales.fr/mesh/D002396"
},
{
"@type": "ListItem",
"position": 9,
"name": "Catécholamines",
"item": "https://questionsmedicales.fr/mesh/D002395"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Catécholamines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Catécholamines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Catécholamines",
"description": "Comment diagnostiquer un excès de catécholamines ?\nQuels tests sont utilisés pour mesurer les catécholamines ?\nQuels symptômes indiquent un déséquilibre des catécholamines ?\nQuelle imagerie peut aider au diagnostic ?\nLes tests génétiques sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Levodopa#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Catécholamines",
"description": "Quels sont les symptômes d'un excès de catécholamines ?\nComment les catécholamines affectent-elles le cœur ?\nPeut-on ressentir des maux de tête ?\nLes troubles de l'humeur sont-ils liés ?\nY a-t-il des symptômes digestifs associés ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Levodopa#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Catécholamines",
"description": "Peut-on prévenir les troubles liés aux catécholamines ?\nQuels changements de mode de vie sont recommandés ?\nLe stress peut-il être évité ?\nLes examens réguliers sont-ils importants ?\nL'éducation sur les symptômes est-elle utile ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Levodopa#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Catécholamines",
"description": "Comment traiter un excès de catécholamines ?\nQuels médicaments sont utilisés ?\nLa chirurgie est-elle toujours nécessaire ?\nY a-t-il des traitements alternatifs ?\nComment surveiller l'efficacité du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Levodopa#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Catécholamines",
"description": "Quelles complications peuvent survenir ?\nLes catécholamines peuvent-elles causer des AVC ?\nY a-t-il un risque de diabète ?\nLes troubles psychologiques sont-ils possibles ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Levodopa#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Catécholamines",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il les risques ?\nLe tabagisme est-il un facteur de risque ?\nLe stress émotionnel joue-t-il un rôle ?\nLes maladies endocriniennes sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Levodopa#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un excès de catécholamines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage sanguin ou urinaire des catécholamines peut confirmer l'excès."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les catécholamines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins et urinaires sont couramment utilisés pour mesurer les niveaux."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un déséquilibre des catécholamines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes comme hypertension, palpitations et anxiété peuvent indiquer un déséquilibre."
}
},
{
"@type": "Question",
"name": "Quelle imagerie peut aider au diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une IRM ou un scanner peut être utilisé pour détecter des tumeurs surrénaliennes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à identifier des syndromes héréditaires liés aux catécholamines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un excès de catécholamines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent hypertension, anxiété, palpitations et sueurs excessives."
}
},
{
"@type": "Question",
"name": "Comment les catécholamines affectent-elles le cœur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des palpitations et une augmentation de la fréquence cardiaque."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des maux de tête ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maux de tête peuvent survenir en raison de l'hypertension causée par les catécholamines."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et l'irritabilité peuvent être exacerbées par un excès de catécholamines."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées et des troubles gastro-intestinaux peuvent également se manifester."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux catécholamines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion du stress et un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels changements de mode de vie sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac sont conseillés."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être évité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est difficile d'éliminer le stress, mais des techniques de relaxation peuvent aider."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers peuvent aider à détecter des problèmes précocement."
}
},
{
"@type": "Question",
"name": "L'éducation sur les symptômes est-elle utile ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, connaître les symptômes permet une détection et une intervention précoces."
}
},
{
"@type": "Question",
"name": "Comment traiter un excès de catécholamines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des médicaments antihypertenseurs et une chirurgie si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bêta-bloquants et les inhibiteurs de la monoamine oxydase sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est réservée aux cas de tumeurs surrénaliennes ou de phéochromocytomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme la méditation peuvent aider à gérer le stress et les symptômes."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers des niveaux de catécholamines et de la pression artérielle sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'hypertension sévère et les maladies cardiaques peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les catécholamines peuvent-elles causer des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hypertension prolongée due aux catécholamines augmente le risque d'AVC."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès de catécholamines peut affecter la régulation de la glycémie, augmentant le risque de diabète."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent être exacerbées par un déséquilibre des catécholamines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, le stress chronique et certaines tumeurs surrénaliennes sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent les risques."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut exacerber les effets des catécholamines sur le système cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le stress émotionnel joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel chronique peut augmenter la production de catécholamines."
}
},
{
"@type": "Question",
"name": "Les maladies endocriniennes sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies endocriniennes peuvent influencer la production de catécholamines."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Seattle Children's Research Institute, Seattle, WA 98101, USA. Electronic address: lili1@uw.edu.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Psychology, University of Washington, Seattle, WA 98105, USA.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China; PKU-IDG/McGovern Institute for Brain Research, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, New Cornerstone Science Laboratory, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA; Department of Pharmacology, University of Washington, Seattle, WA 98195, USA. Electronic address: mbruchas@uw.edu.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Autonomic Medicine Section, CNP/DIR/NINDS/NIH, Bethesda, Maryland (D.G., G.C., P.S.); NIH Academy Enrichment Program, OD/NIH (G.C.); and Sackler Faculty of Medicine, Tel Aviv University, Israel (Y.S.) goldsteind@ninds.nih.gov.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Autonomic Medicine Section, CNP/DIR/NINDS/NIH, Bethesda, Maryland (D.G., G.C., P.S.); NIH Academy Enrichment Program, OD/NIH (G.C.); and Sackler Faculty of Medicine, Tel Aviv University, Israel (Y.S.).
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Autonomic Medicine Section, CNP/DIR/NINDS/NIH, Bethesda, Maryland (D.G., G.C., P.S.); NIH Academy Enrichment Program, OD/NIH (G.C.); and Sackler Faculty of Medicine, Tel Aviv University, Israel (Y.S.).
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. Electronic address: karel@mail.nih.gov.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
From the Department of Internal Medicine (C.D.C.C.v.d.H., L.G., S.T.K., M.P.N., S.K., A.H., L.A.B.J., H.J.L.M.T., M.G.N., N.P.R.), Radboud University Medical Center, Nijmegen, the Netherlands.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands; Department of Medicine, University Hospital Carl Gustav Carus at the TU Dresden, Dresden, Germany.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center, Madrid, Spain.
Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Publications dans "Catécholamines" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Publications dans "Catécholamines" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Publications dans "Catécholamines" :
Monotherapy is the recommended initial treatment for early Parkinson's disease. The pharmacological options for initial treatment include dopaminergic agonists, monoamine oxidase B inhibitors, and lev...
Severe fever with thrombocytopenia syndrome is a hemorrhagic fever caused by a tick-borne infection. The causative agent, Dabie bandavirus, is also called the severe fever with thrombocytopenia syndro...
Levodopa-induced dyskinesia (LID) is a common motor complication in Parkinson's disease (PD). Several genes in the levodopa metabolic pathway, such as COMT, DRDx and MAO-B, were reported associated wi...
Through the whole exome sequencing (WES) and target region sequencing, we aimed to explore the potential associations between common single nucleotide polymorphisms (SNPs) in the levodopa metabolic pa...
Among the 502 PD individuals, 104 (20.7%) were diagnosed with LID. In the discovery stage, we found that COMT rs6269, DRD2 rs6275 and DRD2 rs1076560 were associated with LID. In the replication stage,...
We demonstrated that in the Chinese population, COMT rs6269, DRD2 rs6275 and rs1076560 were significantly associated with LID. And rs6275 was reported associated with LID for the first time....
Elevated circulating homocysteine levels have been associated with cognitive impairment and cardio-cerebro-vascular events. Levodopa treatment of Parkinson's disease tends to further elevate circulati...
In Parkinson's disease, oral medication often fails to achieve sufficient therapeutic success in an advanced stage. At this point, non-oral, device-aided therapies such as the apomorphine pump, the in...
The purpose of this manuscript is to highlight a modern form of the well-known intestinal levodopa pump that allows for the continuation of the oral triple combination of levodopa, carbidopa and entac...
Intrajejunal administration of levodopa is a useful treatment option for advanced Parkinson's disease. The higher acceptance of the smaller pump and the improved user-friendliness have already been re...
Levodopa administration can induce or worsen orthostatic hypotension (OH) in patients with Parkinson's disease (PD). Understanding of acute OH post levodopa (AOHPL) is important for rational drug use ...
490 PD inpatients underwent acute levodopa challenge test (LCT). Supine-to-standing test (STS) was done 4 times during LCT, including before levodopa and every hour post levodopa intake within 3 h. Pa...
33.1% PD patients had OH before drug, 50.8% the same subjects had AOHPL during levodopa effectiveness. PD patients who had better response to levodopa likely to have lower standing mean artery pressur...
AOHPL was very common in PD patients. We suggested that PD patients with risk factors should monitor hemodynamic change during LCT to avoid AOHPL following the introduction or increase of oral levodop...
The gold-standard treatment for Parkinson's disease is levodopa (L-DOPA), which is taken orally and absorbed intestinally. L-DOPA must reach the brain intact to exert its clinical effect; peripheral m...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) resulting in dopamine (DA) deficiency, which...
Treatment of freezing of gait (FoG) and other Parkinson disease (PD) axial symptoms is challenging. Systematic assessments of axial symptoms at progressively increasing levodopa doses are lacking. We ...
We performed a pre-/postinterventional study including patients treated with levodopa/carbidopa intestinal gel infusion (LCIG) with disabling FoG in daily-ON condition. Patients were evaluated at thei...
We evaluated 16 patients with a mean age of 69 ± 9.4 years and treated with LCIG for a mean of 2.2 ± 2.1 years. FoG improved in 83.3% of patients by increasing the levodopa doses. The number of FoG ep...
In a short-term evaluation, the increase of LCIG dose can improve "dopa-resistant" FoG and gait issues in most advanced PD patients with overall good control of motor symptoms in the absence of clinic...
INTRODUCTION: Parkinson disease (PD) affects approximately 1% of women and men worldwide, particularly older than 60 years. It is a multisystem and neurodegenerative disease with genetics and environm...